MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
// Related Deep Analysis
NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine Ahead of Schedule
Read the full analysis →
NRx Receives FDA Approval for Preservative-Free Ketamine
Regulatory
NRX Pharmaceuticals, Inc.
Nov 2
AI-curated analysis for informational purposes only — not investment advice.
NRx received FDA approval for its preservative-free ketamine andase Raywood deal
Read the full filing at sec.gov →